RG 7258Alternative Names: RG7258
Latest Information Update: 31 Jul 2012
At a glance
- Originator Roche
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Cytokine receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 26 Jul 2012 Discontinued - Phase-I for Asthma in Switzerland (Parenteral)
- 01 Feb 2012 Phase-I clinical trials in Asthma in Switzerland (Parenteral)